J R Wingard
Overview
Explore the profile of J R Wingard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
3630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unnikrishnan A, Glover S, Norkina O, Wingard J, Norkin M
Bone Marrow Transplant
. 2017 Jun;
52(8):1204-1205.
PMID: 28581471
No abstract available.
2.
Maziarz R, Brazauskas R, Chen M, McLeod A, Martino R, Wingard J, et al.
Bone Marrow Transplant
. 2016 Dec;
52(2):270-278.
PMID: 27991895
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT). However, little is known about the impact of prior IFI on survival. Patients with pre-transplant...
3.
Moriyama B, Obeng A, Barbarino J, Penzak S, Henning S, Scott S, et al.
Clin Pharmacol Ther
. 2016 Dec;
102(1):45-51.
PMID: 27981572
Voriconazole, a triazole antifungal agent, demonstrates wide interpatient variability in serum concentrations, due in part to variant CYP2C19 alleles. Individuals who are CYP2C19 ultrarapid metabolizers have decreased trough voriconazole concentrations,...
4.
Riwes M, Leather H, Neal D, Bennett C, Sugrue M, Cline C, et al.
Bone Marrow Transplant
. 2016 Apr;
51(9):1228-32.
PMID: 27088382
Several studies have suggested an association of mannose-binding lectin (MBL) deficiency with infections. In this study, we investigated the association between MBL deficiency and invasive fungal disease (IFD) in hematologic...
5.
Riches M, Trifilio S, Chen M, Ahn K, Langston A, Lazarus H, et al.
Bone Marrow Transplant
. 2016 Feb;
51(2):322.
PMID: 26838373
No abstract available.
6.
Williams K, Ahn K, Chen M, Aljurf M, Agwu A, Chen A, et al.
Bone Marrow Transplant
. 2016 Jan;
51(4):573-80.
PMID: 26726945
Pneumocystis jiroveci pneumonia (PJP) is associated with high morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Little is known about PJP infections after HSCT because of the rarity of...
7.
Riches M, Trifilio S, Chen M, Ahn K, Langston A, Lazarus H, et al.
Bone Marrow Transplant
. 2015 Nov;
51(2):277-82.
PMID: 26524262
Risk factors for non-Aspergillus mold infection (NAMI) and the impact on transplant outcome are poorly assessed in the current era of antifungal agents. Outcomes of 124 patients receiving allogeneic hematopoietic...
8.
Inamoto Y, Shah N, Savani B, Shaw B, Abraham A, Ahmed I, et al.
Bone Marrow Transplant
. 2015 Mar;
50(8):1013-23.
PMID: 25822223
Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and without reaching a plateau overtime. A working group...
9.
Bachanova V, Burns L, Wang T, Carreras J, Gale R, Wiernik P, et al.
Bone Marrow Transplant
. 2014 Nov;
50(2):197-203.
PMID: 25402415
Alternative donor transplantation is increasingly used for high-risk lymphoma patients. We analyzed 1593 transplant recipients (2000-2010) and compared transplant outcomes in recipients of 8/8 allele HLA-A, -B, -C and DRB1...
10.
Joshi S, Savani B, Chow E, Gilleece M, Halter J, Jacobsohn D, et al.
Bone Marrow Transplant
. 2014 Jan;
49(4):477-84.
PMID: 24419521
With broadening indications, more options for hematopoietic cell transplantation (HCT) and improvement in survival, the number of long-term HCT survivors is expected to increase steadily. Infertility is a frequent problem...